Loading…

Insertion of double J stent as a therapeutic test in management of adults presenting with loin pain and equivocal ureteropelvic junction obstruction

Purpose To evaluate temporary double J ureteric stenting (TDJS) as a test to diagnose ureteropelvic junction obstruction (UPJO) in equivocal cases. Materials and methods One hundred and nine consecutive adult patients with loin pain and ipsilateral equivocal UPJO (EqUPJO) on radioisotope diuretic re...

Full description

Saved in:
Bibliographic Details
Published in:World journal of urology 2010-06, Vol.28 (3), p.373-378
Main Authors: Osman, Tarek, Fawaz, Khaled, Abdelmaksoud, Alaa, Eltahawy, Ihab, Safa, Wael, El Zayat, Tarek, El Sadek, Dahlia, El Halaby, Rafik
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To evaluate temporary double J ureteric stenting (TDJS) as a test to diagnose ureteropelvic junction obstruction (UPJO) in equivocal cases. Materials and methods One hundred and nine consecutive adult patients with loin pain and ipsilateral equivocal UPJO (EqUPJO) on radioisotope diuretic renogram (RDR) were enrolled in the present study. All patients underwent TDJS for 3 weeks. According to the response (relief of pain) to TDJS, which was assessed by visual analogue pain score (VAPS), patient preference and further management, patients were classified into five groups: Group Ia non-responders who elected conservative treatment for their condition, Group Ib non-responders who elected intervention, Group IIa responders who elected conservative treatment and Group IIb responders who elected intervention. Last group patients were randomized to either early (Group IIb 1 ) or delayed intervention 3 months later (Group IIb 2 ). Intervention was in the form of pyeloplasty (24 patients) and endopyelotomy (38 patients). All patients were followed up by measuring VAPS and RDR. Results After at least 6 months from management decision, 97 patients were available for evaluation. The VAPS dropped by 21.25% ( P  
ISSN:0724-4983
1433-8726
DOI:10.1007/s00345-009-0464-3